PLA2G7 and ischemic stroke: Previous studies have shown that the levels of several blood biological markers (ultrasensitive C-reactive protein, lipoprotein-associated phospholipase A2, and metalloproteinase-9) are increased to varying degrees during the acute phase of ischemic stroke [14], but changes in a single marker have limitations for the diagnosis of ischemic stroke.